2 documents found, page 1 of 1

Sort by Issue Date

Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in E...

Kirakosyan, O; Reimann, M; Andersen, AB; Bjarnason, A; Bakos, Á; Dyrhol-Riise, AM; McLaughlin, AM; Nita, C; Pieridou, D; Chesov, D; Davidavičienė, EV

"Background: Anecdotal information suggests that clinical practice regarding the use of putative hepatoprotective agents in TB treatment varies across countries in the WHO European Region. Methods: Between November 2023 and May 2024, we conducted a standardised questionnaire survey on the use of putative hepatoprotective agents in patients receiving TB treatment among Tuberculosis Network European Trials Group ...


Viewpoint on WHO implementation guidance on tuberculosis infection prevention a...

Akkerman, OW; Migliori, GB; Falzon, D; Garcia-Basteiro, AL; Kanchar, A; Konstantynovska, O; Eyuboglu, FO; Duarte, R


2 Results

Queried text

Refine Results

Author





















Date



Document Type



Access rights


Resource